Silencing of human HTT by targeted CRISPR/dCas9-mediated epigenetic editing. - Tay YL; Thomson SB; Hnatova S; Ng S; Teo SR; McCallum R; Sim B; Tarantini L; Tai FL; Bollati V; Loh M; Hayden MR; et al. (Journal of Huntington's disease, 2026)